Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Withus Pharmaceutical Co Ltd
Net Income (Common)
Withus Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
|
Net Income (Common)
₩6.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Net Income (Common)
₩191.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Net Income (Common)
₩267B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Net Income (Common)
₩169.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
70%
|
CAGR 10-Years
1%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Net Income (Common)
₩5.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Net Income (Common)
₩20.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Withus Pharmaceutical Co Ltd
Glance View
Withus Pharmaceutical Co., Ltd. manufactures and sells prescription drugs. The company is headquartered in Seoul, Seoul and currently employs 217 full-time employees. The company went IPO on 2020-07-03. The firm's main products include circulatory agents, musculoskeletal agents, digestive agents, antibiotics and other prescription drugs. And the Company is engaged in contract manufacturing operation(CMO).
See Also
What is Withus Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
6.3B
KRW
Based on the financial report for Sep 30, 2025, Withus Pharmaceutical Co Ltd's Net Income (Common) amounts to 6.3B KRW.
What is Withus Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-6%
Over the last year, the Net Income (Common) growth was -7%. The average annual Net Income (Common) growth rates for Withus Pharmaceutical Co Ltd have been 5% over the past three years , -6% over the past five years .
